Is Doppel Farmaceutici S.r.l. FDA approved?

Doppel Farmaceutici S.r.l. holds 2 FDA-registered establishments in Italy. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Doppel Farmaceutici S.r.l.'s drugs manufactured?

The FDA register lists Cortemaggiore; Quinto de' Stampi - Rozzano. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.

What drugs does Doppel Farmaceutici S.r.l. make?

10 products are listed under Doppel Farmaceutici S.r.l. in the openFDA NDC Directory, most often as tablet; suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Doppel Farmaceutici S.r.l.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 2
Active NDC listings: 10
Live patents: 0
Countries: 1
Base: Italy

Authorisation

Registered operations

Analytical testing2Labelling2Finished drug manufacture2Packaging2

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Doppel Farmaceutici S.r.l.	Via Martiri delle Foibe 1, Cortemaggiore, Piacenza 29016, Italy (ITA)	Analytical testing, Labelling, Finished drug manufacture, Packaging	3004797574447197278
Doppel Farmaceutici S.r.l.	Via Volturno, 48, Quinto de' Stampi - Rozzano, Milan 20089, Italy (ITA)	Analytical testing, Labelling, Finished drug manufacture, Packaging	3003877372434168966

Catalogue

Drug listings by form and route

10 active NDC listings: 10 human prescription drug. By marketing category: ANDA 10.

Dosage form	NDCs
tablet	8
suspension	2

Route	NDCs
oral	10

Labeller name on the listing	NDCs
doppel farmaceutici s.r.l.	10

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
Deflazacort	Deflazacort	tablet, oral	81806-204ANDA
Deflazacort	Deflazacort	tablet, oral	81806-206ANDA
Deflazacort	Deflazacort	tablet, oral	81806-207ANDA
Deflazacort	Deflazacort	tablet, oral	81806-208ANDA
Deflazacort Oral Suspension	Deflazacort	suspension, oral	81806-200ANDA
JAYTHARI	Deflazacort	tablet, oral	81806-174ANDA
JAYTHARI	Deflazacort	tablet, oral	81806-175ANDA
JAYTHARI	Deflazacort	tablet, oral	81806-176ANDA
JAYTHARI	Deflazacort	tablet, oral	81806-177ANDA
JAYTHARI Oral Suspension	Deflazacort	suspension, oral	81806-213ANDA

Compare

Comparable companies in Italy

Erregierre SpA2 sites · 36 NDC
Novo Nordisk Production Belgium SA2 sites · 24 NDC
Indena SpA2 sites · 15 NDC
Italfarmaco S.A.2 sites · 15 NDC
Lusochimica SPA2 sites · 13 NDC
Trifarma S.p.A.2 sites · 10 NDC
CHEMI SpA2 sites · 4 NDC
OPOCRIN SPA2 sites · 2 NDC
ALFASIGMA SPA2 sites · 1 NDC
AMSA Anonima Materie Sintetiche ED Affini Spa2 sites · 0 NDC

Enquiry

Common questions

Is Doppel Farmaceutici S.r.l. FDA approved?: Doppel Farmaceutici S.r.l. holds 2 FDA-registered establishments in Italy. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Doppel Farmaceutici S.r.l.'s drugs manufactured?: The FDA register lists Cortemaggiore; Quinto de' Stampi - Rozzano. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does Doppel Farmaceutici S.r.l. make?: 10 products are listed under Doppel Farmaceutici S.r.l. in the openFDA NDC Directory, most often as tablet; suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.